The stock price of Caredx Inc (NASDAQ: CDNA) has surged by 4.25 when compared to previous closing price of 21.10, but the company has seen a -5.92% decline in its stock price over the last five trading sessions. zacks.com reported 2025-02-27 that BCS, CDNA, PGR, EZPW and EVER have been added to the Zacks Rank #1 (Strong Buy) List on February 27, 2025.
Is It Worth Investing in Caredx Inc (NASDAQ: CDNA) Right Now?
The 36-month beta value for CDNA is also noteworthy at 1.96. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 1 rating it as “overweight,” 3 rating it as “hold,” and 0 rating it as “sell.”
The public float for CDNA is 50.24M, and at present, short sellers hold a 9.51% of that float. The average trading volume of CDNA on February 27, 2025 was 810.54K shares.
CDNA’s Market Performance
The stock of Caredx Inc (CDNA) has seen a -5.92% decrease in the past week, with a -3.69% drop in the past month, and a -4.90% fall in the past quarter. The volatility ratio for the week is 7.23%, and the volatility levels for the past 30 days are at 6.37% for CDNA. The simple moving average for the past 20 days is -4.91% for CDNA’s stock, with a -2.70% simple moving average for the past 200 days.
Analysts’ Opinion of CDNA
Many brokerage firms have already submitted their reports for CDNA stocks, with Wells Fargo repeating the rating for CDNA by listing it as a “Equal Weight.” The predicted price for CDNA in the upcoming period, according to Wells Fargo is $24 based on the research report published on January 15, 2025 of the current year 2025.
Wells Fargo, on the other hand, stated in their research note that they expect to see CDNA reach a price target of $28. The rating they have provided for CDNA stocks is “Underweight” according to the report published on August 28th, 2024.
BTIG Research gave a rating of “Buy” to CDNA, setting the target price at $40 in the report published on August 19th of the previous year.
CDNA Trading at -2.67% from the 50-Day Moving Average
After a stumble in the market that brought CDNA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -36.87% of loss for the given period.
Volatility was left at 6.37%, however, over the last 30 days, the volatility rate increased by 7.23%, as shares sank -2.62% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -6.51% lower at present.
During the last 5 trading sessions, CDNA fell by -6.03%, which changed the moving average for the period of 200-days by +98.64% in comparison to the 20-day moving average, which settled at $23.13. In addition, Caredx Inc saw 2.74% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CDNA starting from Novack Jeffrey Adam, who sale 3,512 shares at the price of $23.30 back on Feb 04 ’25. After this action, Novack Jeffrey Adam now owns 104,677 shares of Caredx Inc, valued at $81,829 using the latest closing price.
Jeffrey Adam Novack, the Officer of Caredx Inc, proposed sale 3,512 shares at $23.32 during a trade that took place back on Feb 04 ’25, which means that Jeffrey Adam Novack is holding shares at $81,900 based on the most recent closing price.
Stock Fundamentals for CDNA
Current profitability levels for the company are sitting at:
- 0.15 for the present operating margin
- 0.75 for the gross margin
The net margin for Caredx Inc stands at 0.19. The total capital return value is set at 0.13. Equity return is now at value -43.02, with -29.35 for asset returns.
Based on Caredx Inc (CDNA), the company’s capital structure generated 0.06 points at debt to capital in total, while cash flow to debt ratio is standing at 0.35.
Currently, EBITDA for the company is 40.77 million with net debt to EBITDA at -1.41. When we switch over and look at the enterprise to sales, we see a ratio of 3.21. The receivables turnover for the company is 5.17for trailing twelve months and the total asset turnover is 0.68. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.10.
Conclusion
In summary, Caredx Inc (CDNA) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
